Clinical • Combination therapy • PD(L)-1 Biomarker • IO biomarker
|
EGFR (Epidermal growth factor receptor) • HER-2 (Human epidermal growth factor receptor 2) • RET (Ret Proto-Oncogene) • CTLA4 (Cytotoxic T-Lymphocyte Associated Protein 4)
|
EGFR mutation • HER-2 amplification • HER-2 mutation • RET fusion • EGFR amplification • EGFR exon 20 insertion • HER-2 exon 20 insertion • RET mutation • EGFR exon 20 mutation
|
carboplatin • paclitaxel • pemetrexed • erfonrilimab (KN046)